[1] WHO. WHO recommended surveillance standards. 1999. https://www.who.int/publications/i/item/who-recommended-surveillance-standards. [1999-2-22].https://www.who.int/publications/i/item/who-recommended-surveillance-standards
[2] Dritsas E, Trigka M. Supervised machine learning models to identify early-stage symptoms of SARS-CoV-2. Sensors (Basel) 2022;23(1):40. http://dx.doi.org/10.3390/s23010040CrossRef
[3] Briana DD, Papaevangelou V, Syridou G, Paparizou K, Siafakas N, Konstantinidou AE, et al. Clinical symptoms associated with laboratory findings and placental histopathology in full-term, non-infected neonates born to severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) positive mothers. J Matern Fetal Neonatal Med 2022;35(25):8706 − 9. http://dx.doi.org/10.1080/14767058.2021.1998894CrossRef
[4] Zavala M, Ireland G, Amin-Chowdhury Z, Ramsay ME, Ladhani SN. Acute and persistent symptoms in children with polymerase chain reaction (PCR)-confirmed severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection compared with test-negative children in England: active, prospective, national surveillance. Clin Infect Dis 2022;75(1):e191 − 200. http://dx.doi.org/10.1093/cid/ciab991CrossRef
[5] Hurst JH, McCumber AW, Aquino JN, Rodriguez J, Heston SM, Lugo DJ, et al. Age-related changes in the nasopharyngeal microbiome are associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection and symptoms among children, adolescents, and young adults. Clin Infect Dis 2022;75(1):e928 − 37. http://dx.doi.org/10.1093/cid/ciac184CrossRef
[6] Falsey AR, Walsh EE, Osborne RH, Vandendijck Y, Ren XH, Witek J, et al. Comparative assessment of reported symptoms of influenza, respiratory syncytial virus, and human metapneumovirus infection during hospitalization and post-discharge assessed by Respiratory Intensity and Impact Questionnaire. Influenza Other Respir Viruses 2022;16(1):79 − 89. http://dx.doi.org/10.1111/irv.12903CrossRef
[7] Larsson E, Johansson S, Frøbert O, Nordenskjöld A, Athlin S. Evaluation of the ImmuView RSV test for rapid detection of respiratory syncytial virus in adult patients with influenza-like symptoms. Microbiol Spectr 2021;9(3):e0093721. http://dx.doi.org/10.1128/Spectrum.00937-21CrossRef
[8] Ziegler T, Moen A, Zhang WQ, Cox NJ. Global influenza surveillance and response system: 70 years of responding to the expected and preparing for the unexpected. Lancet 2022;400(10357):981 − 2. http://dx.doi.org/10.1016/S0140-6736(22)01741-XCrossRef
[9] Feng YN, Zhao X, Chen ZX, Nie K, Yin ZY, Xia Y, et al. Genomic surveillance for SARS-CoV-2 variants of concern from imported COVID-19 cases - the mainland of China, 2021. China CDC Wkly 2022;4(31):680 − 4. http://dx.doi.org/10.46234/ccdcw2022.144CrossRef
[10] Chinese National Influenza Center. China flu report. 2023. https://ivdc.chinacdc.cn/cnic/zyzx/lgzb/202302/t20230201_263574.htm. [2023-2-1]. (In Chinese). https://ivdc.chinacdc.cn/cnic/zyzx/lgzb/202302/t20230201_263574.htm
[11] Chinese National Influenza Center. China flu report. 2023. https://ivdc.chinacdc.cn/cnic/en/Surveillance/WeeklyReport/202301/t20230127_263525.htm. [2023-2-1].https://ivdc.chinacdc.cn/cnic/en/Surveillance/WeeklyReport/202301/t20230127_263525.htm
[12] Takashita E, Watanabe S, Hasegawa H, Kawaoka Y. Are twindemics occurring? Influenza Other Respir Viruses 2023;17(1):e13090. http://dx.doi.org/10.1111/irv.13090.http://dx.doi.org/10.1111/irv.13090